Xue HM, Chen P, Zhu XJ, Jiao JY, Wang P. Robot-assisted partial splenectomy for benign splenic tumors: Four case reports. World J Clin Oncol 2024; 15(10): 1366-1375 [DOI: 10.5306/wjco.v15.i10.1366]
Corresponding Author of This Article
Peng Wang, MD, PhD, Chief Physician, Professor, Department of General Surgery, The Affiliated Hospital of Nantong University, No. 20 Xisi Road, Nantong 226001, Jiangsu Province, China. dankongwang@ntu.edu.cn
Research Domain of This Article
Robotics
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Oncol. Oct 24, 2024; 15(10): 1366-1375 Published online Oct 24, 2024. doi: 10.5306/wjco.v15.i10.1366
Robot-assisted partial splenectomy for benign splenic tumors: Four case reports
Hui-Min Xue, Peng Chen, Xiao-Jun Zhu, Jing-Yi Jiao, Peng Wang
Hui-Min Xue, Xiao-Jun Zhu, Peng Wang, Department of General Surgery, The Affiliated Hospital of Nantong University, Nantong 226001, Jiangsu Province, China
Peng Chen, Jing-Yi Jiao, Medical School, Nantong University, Nantong 226001, Jiangsu Province, China
Co-first authors: Hui-Min Xue and Peng Chen.
Author contributions: All authors contributed to the study conceptualization and design; Wang P and Xue HM were responsible for funding acquisition; Material preparation, data collection and analysis were performed by Xue HM and Chen P; The first draft of the manuscript was written by Xue HM; Zhu XJ and Jiao JY contributed to manuscript data analysis and image collection; The manuscript was critically revised by Wang P; All authors read and approved the final manuscript.
Supported byNantong “14th Five-Year” Science and Education to Strengthen Health Project, General Surgery Medical Key Discipline, No. 42.
Informed consent statement: All study participants or their legal guardians provided informed written consent prior to study enrolment.
Conflict-of-interest statement: The authors declare that they have no conflicts of interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Peng Wang, MD, PhD, Chief Physician, Professor, Department of General Surgery, The Affiliated Hospital of Nantong University, No. 20 Xisi Road, Nantong 226001, Jiangsu Province, China. dankongwang@ntu.edu.cn
Received: April 27, 2024 Revised: August 19, 2024 Accepted: September 2, 2024 Published online: October 24, 2024 Processing time: 154 Days and 21.9 Hours
Abstract
BACKGROUND
Robotic-assisted partial splenectomy (RAPS) is a superior approach for treating splenic cysts and splenic hemangiomas, as it preserves the immune function of the spleen and reduces the risk of overwhelming post splenectomy infection. Currently, there are no standardized guidelines for performing a partial splenectomy.
CASE SUMMARY
Four patients with splenic cysts or splenic hemangiomas were treated by RAPS. Critical aspects with RAPS include carefully dissecting the splenic pedicle, accurately identifying and ligating the supplying vessels of the targeted segment, and ensuring precise hemostasis during splenic parenchymal transection. Four successful RAPS cases are presented, where the tumors were removed by pretreating the splenic artery, dissecting and ligating the corresponding segmental vessels of the splenic pedicle, transecting the ischemic segment of the spleen, and using electrocautery for optimal hemostasis. Four patients underwent successful surgeries with minimal bleeding during the procedure, and there were no signs of bleeding or recurrence postoperatively.
CONCLUSION
Four cases confirm the feasibility and superiority of RAPS for the treatment of benign splenic tumors.
Core Tip: Robotic-assisted partial splenectomy (RAPS) is a superior approach for treating splenic cysts and splenic hemangiomas, as it preserves the immune function of the spleen and reduces the risk of overwhelming post splenectomy infection. Currently, there are no standardized guidelines for performing a partial splenectomy. This paper reports four cases of benign splenic tumors managed successfully by robotic-assisted partial splenectomy. This article provides the first comprehensive account of the detailed surgical procedure. RAPS demonstrates notable advantages in the treatment of benign splenic diseases.
